| Literature DB >> 29755856 |
Wei Zhang1,2, Guo-Ji Yang3, Shi-Xian Wu4, Dong-Qing Li5, Ying-Bo Xu1, Cheng-Hong Ma1, Jun-Ling Wang2, Wei-Wen Chen1,2.
Abstract
Osteoporosis (OP) and osteoporotic fractures are becoming a serious health care issue in the world. Calcium and vitamin D are the basic treatment for osteoporosis. Nonetheless, they do not effectively reduce the incidences of fracture. Currently approved treatments for osteoporosis include selective estrogen receptor modulators (SERMs), bisphosphonates, denosumab, teriparatide, calcitonin and others. However, the appearance of some adverse effects including atypical fracture and breast cancer has limited long-term treatments above mentioned. Therefore, treatment decision should be made on an individual basis, taking into account the relative benefits and risks in different patients. Bone metabolism test helps to assess the patient's condition, which may ultimately lead to therapeutic options and better clinical outcomes.Entities:
Keywords: 25(OH)D; Osteoporosis; Tregs; androgen; bone turnover markers; calcitonin; calcium; cytokines; estrogen; parathyroid hormone
Year: 2018 PMID: 29755856 PMCID: PMC5944817
Source DB: PubMed Journal: Am J Clin Exp Immunol